What is the appropriate evaluation and management of septic arthritis?

Septic Arthritis: Evaluation and Management

Septic arthritis requires immediate joint drainage (surgical or arthrocentesis) combined with empiric IV antibiotics for 3-4 weeks, with vancomycin as first-line therapy for MRSA coverage until culture results guide definitive treatment.

Immediate Diagnostic Approach

Clinical Evaluation

Look for the classic presentation of acute joint pain, fever, and inability to bear weight. However, recognize that this triad appears in only ~50% of cases 1, 2. The Kocher criteria help distinguish septic arthritis from transient synovitis, particularly in the hip 2:

• Fever >101.3°F
• ESR ≥40 mm/hour
• WBC ≥12,000 cells/mm³
• Inability to bear weight
• C-reactive protein >2.0 mg/dL (recently validated as highly predictive) 2

Meeting all criteria approaches 100% likelihood of septic arthritis.

Laboratory Workup

• Joint aspiration is mandatory for diagnosis 3, 4
• Send synovial fluid for:
  • Gram stain and culture (gold standard) 5
  • Cell count with differential
  • Crystal analysis to exclude gout/pseudogout
• Blood cultures (positive in ~50% of cases)
• Inflammatory markers: ESR, CRP, WBC

Imaging Strategy

Initial imaging:

• Radiographs first - readily available and inexpensive, though low sensitivity early 5
• Ultrasound - excellent for detecting effusions and guiding aspiration in real-time without radiation 5

Advanced imaging when diagnosis unclear:

• MRI - most sensitive modality, detects bone marrow and soft tissue changes within 24 hours 4, 5
• CT - useful in emergency settings for rapid assessment and evaluating complications like osteolysis or sequestra 4

Surgical Management

Joint drainage must always be performed 1, 3. The method depends on the joint:

• Hip joints: Require open surgical drainage 3
• Other joints: Arthrocentesis may suffice for early disease, but arthroscopic or open drainage preferred for:
  • Large effusions
  • Loculated fluid
  • Failed response to initial aspiration
  • Advanced disease (Gächter stage III-IV) 6

Prosthetic joint infections: Device removal is strongly recommended 3. If removal impossible, chronic suppression with antibiotics is required 3.

Antibiotic Therapy

Empiric Treatment (Start Immediately After Cultures Obtained)

For MRSA coverage (most common pathogen):

• IV vancomycin - primary recommendation 1
• Consider adding rifampin for improved outcomes, especially in bone involvement 1

Alternative agents:

• Linezolid 600 mg IV/PO twice daily 1
• Daptomycin 6 mg/kg/day IV 1
• Clindamycin 10-13 mg/kg/dose IV every 6-8 hours (only if local MRSA resistance <10%) 1

Pathogen-Specific Considerations

• Staphylococcus aureus: Most common overall (47.6% in recent series) 6
• Streptococci and Gram-negatives: Less common 7
• Special populations:
  • Neonates: Consider Group B Streptococcus
  • Children <4 years: Consider Kingella kingae
  • Sickle cell disease: Consider Salmonella spp. 2

Duration of Therapy

Standard native joint septic arthritis:

• 3-4 weeks total for uncomplicated cases 1, 8
• Extend to 6 weeks if imaging shows concomitant osteomyelitis 8

Prosthetic joint infections with device retention:

• 2 weeks IV therapy plus rifampin
• Followed by 3-6 months oral therapy (rifampin plus fluoroquinolone, TMP-SMX, tetracycline, or clindamycin) 1

Route of administration:

• Start with IV therapy
• Transition to oral therapy based on clinical response (typically after 7-10 days if improving) 1
• Oral therapy acceptable if patient stable, no bacteremia, and organism susceptible 1

Monitoring Response

Track these parameters:

• CRP normalizes ~43 days post-surgery 6
• ESR normalizes ~54 days post-surgery 6
• Clinical improvement: Pain reduction, fever resolution, improved mobility
• Repeat aspiration if no clinical improvement within 48-72 hours

Critical Pitfalls to Avoid

1. Delayed diagnosis: Mortality ranges 2-15% 7. Don't wait for imaging if clinical suspicion high—aspirate immediately.

2. Inadequate drainage: Medical therapy alone fails without proper joint evacuation 3, 8.

3. Vancomycin failures: Reported in 35-46% of osteomyelitis cases 1. Consider adding rifampin or switching to alternative agents if no improvement.

4. Prosthetic joints: Attempting medical management without device removal typically fails 3. Plan for two-stage revision with 3-6 months between stages.

5. Concomitant osteomyelitis: Present in up to 30% of pediatric cases and requires extended therapy 1. Always image to assess bone involvement.

6. Advanced disease (Gächter stage III-IV): Higher recurrence risk even with appropriate treatment 6. These patients need closer monitoring and may require repeat procedures.

Special Populations

Immunocompromised patients: Higher risk for polyarticular involvement (average 3.5 joints) and increased mortality 9. Consider broader coverage and longer treatment duration.

Candida septic arthritis (rare but important):

• Fluconazole 400 mg daily for 6 weeks OR echinocandin for 2 weeks followed by fluconazole for ≥4 weeks 3
• Surgical drainage still mandatory 3